A. Stormorken

发表

Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations

K. Heimdal, P. Møller, L. Mæhle, 2004, Familial Cancer.

MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.

P. Møller, J. Kleibeuker, J. Kleibeuker, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk reducing mastectomy, breast reconstruction and patient satisfaction in Norwegian BRCA1/2 mutation carriers.

P. Møller, E. Schlichting, L. Mæhle, 2014, Breast.

syndrome (hereditary non-polyposis cancer) Guidelines for the clinical management of Lynch

P. Møller, J. Burn, S. Hodgson, 2007 .

Guidelines for the clinical management of Lynch

P. Møller, G. Capellá, J. Mecklin, 2007 .

Immunohistochemistry identifies carriers of mismatch repair gene defects causing hereditary nonpolyposis colorectal cancer.

K. Heimdal, P. Møller, E. Kure, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The inframe MSH2 codon 596 deletion is linked with HNPCC and associated with lack of MSH2 protein in tumours

K. Heimdal, P. Møller, A. Lindblom, 2004, Familial Cancer.

Prediction of the outcome of genetic testing in HNPCC kindreds using the revised Amsterdam criteria and immunohistochemistry

P. Møller, R. Fodde, W. Müller, 2004, Familial Cancer.

Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients

P. Møller, H. Meijers-Heijboer, G. Kenter, 2000, The Journal of pathology.

Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds

P. Møller, G. Evans, H. Järvinen, 2009, Journal of Medical Genetics.

The Norwegian PMS2 founder mutation c.989-1G > T shows high penetrance of microsatellite instable cancers with normal immunohistochemistry

P. Møller, L. Mæhle, W. Sjursen, 2014, Hereditary cancer in clinical practice.

High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR-mutation carriers

P. Møller, G. Capellá, J. Burn, 2008, Familial Cancer.

MUTYH Mutations Do Not Cause HNPCC or Late Onset Familial Colorectal Cancer

P. Møller, E. Hovig, P. A. Andresen, 2006, Hereditary cancer in clinical practice.

A woman in her thirties with breast cancer and bilateral goitre.

Kjersti Jørgensen, E. Sigstad, A. Stormorken, 2017, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts

P. Møller, G. Capellá, A. Lindblom, 2013, Gut.

The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation

P. Møller, L. Mæhle, M. Holmen, 2014, Breast Cancer Research and Treatment.

Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers

P. Møller, L. Mæhle, L. F. Engebretsen, 2010, Journal of Medical Genetics.

Guidelines for the clinical management of familial adenomatous polyposis (FAP)

P. Møller, G. Capellá, S. Tejpar, 2008, Gut.

Peutz–Jeghers syndrome: a systematic review and recommendations for management

P. Møller, G. Capellá, S. Tejpar, 2010, Gut.

[Hereditary colorectal cancer].

K. Heimdal, P. Møller, J. Apold, 1999, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Germ-Line Mutations in Mismatch Repair Genes Associated with Prostate Cancer

P. Møller, R. Eeles, R. Kvåle, 2009, Cancer Epidemiology, Biomarkers & Prevention.

Familial endometrial cancer in female carriers of MSH6 germline mutations

P. Møller, H. Meijers-Heijboer, R. Hofstra, 1999, Nature Genetics.

Prevention of colorectal cancer by colonoscopic surveillance in families with hereditary colorectal cancer

P. Møller, L. Mæhle, E. Grindedal, 2007, Scandinavian journal of gastroenterology.

Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.

P. Møller, H. V. van Houwelingen, G. Kenter, 2004, Gastroenterology.

Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program

P. Møller, S. Narod, L. Mæhle, 2013, Breast Cancer Research and Treatment.

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)

P. Møller, G. Capellá, J. Mecklin, 2007, Journal of Medical Genetics.

A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

R. Eeles, Z. Kote-Jarai, F. Hamdy, 2021, The Lancet. Oncology.

Recommendations to improve identification of hereditary and familial colorectal cancer in Europe

P. Møller, G. Capellá, A. Lindblom, 2010, Familial Cancer.

Estimated prevalence of hereditary cancers and the need for surveillance in a Norwegian county, Telemark

P. Møller, G. Hoff, E. Grindedal, 2006, Scandinavian journal of gastroenterology.

Quality of Life and its Relation to Cancer-Related Stress in Women of Families with Hereditary Cancer without Demonstrated Mutation

K. Heimdal, P. Møller, L. Mæhle, 2006, Quality of Life Research.

The Norwegian PMS2 founder mutation c.989-1G > T shows high penetrance of microsatellite instable cancers with normal immunohistochemistry

P. Møller, L. Mæhle, W. Sjursen, 2014, Hereditary cancer in clinical practice.

APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis

T. Berg, S. Steigen, O. Norum, 2018, Familial Cancer.

K. Õunap, P. Ilves, R. Sijmons, 2023, Molecular genetics & genomic medicine.

Guidelines for the clinical management of familial adenomatous polyposis (FAP)

P. Møller, G. Capellá, S. Tejpar, 2008, Gut.

Peutz–Jeghers syndrome: a systematic review and recommendations for management

S. Tejpar, H. Järvinen, J. Burn, 2010, Gut.

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)

G. Capellá, C. Engel, J. Burn, 2007, Journal of Medical Genetics.

Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome

L. Mæhle, E. Grindedal, A. Stormorken, 2024, The Prostate.